Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03255291
Other study ID # 201706063
Secondary ID R01CA190391
Status Completed
Phase N/A
First received
Last updated
Start date June 27, 2017
Est. completion date January 3, 2019

Study information

Verified date January 2020
Source Washington University School of Medicine
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Epidemiology seeks to improve public health by identifying risk factors for cancer and other diseases and conveying that information to relevant audiences (e.g., physicians, the public). The audience is presumed to understand and use that information to make appropriate decisions about lifestyle behaviors and medical treatments. Yet, even though a single risk factor can affect the risk of multiple health outcomes, this information is seldom communicated to people in a way that optimizes their understanding of the importance of engaging in a single healthy behavior. Providing individuals with the ability to understand how a single behavior (obtaining sufficient physical activity) could affect their risk of developing multiple diseases could foster a more coherent and meaningful picture of the behavior's importance in reducing health risks, increase motivation and intentions to engage in the behavior, and over time improve public health.

The proposed study translates epidemiological data about five diseases that cause significant morbidity and mortality (i.e., colon cancer, breast cancer (women), heart disease, diabetes, and stroke) into a visual display that conveys individualized risk estimates in a comprehensible, meaningful, and useful way to diverse lay audiences.


Recruitment information / eligibility

Status Completed
Enrollment 554
Est. completion date January 3, 2019
Est. primary completion date January 3, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 30 Years to 64 Years
Eligibility Inclusion Criteria:

- 30-64 years of age

- Less than (3) relevant comorbidities (diabetes, heart disease, stroke, and cancer, where cancer counts as (2) comorbidities for women but (1) for men)

- Having a SMS capable mobile phone that is not shared with anyone else

Exclusion Criteria:

- Not meeting national guidelines for aerobic physical activity (i.e., at least 150 minutes per week of moderate intensity aerobic physical activity)

- Participants from HRPO# 201501028 will be ineligible for this study

- Uses text messaging less than once per month

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Risk Assessment App
The App provides participants with personalized risk results for colon cancer, breast cancer (women), heart disease, diabetes, and stroke.
Audio Recording - Sleep
-Participants imagine themselves improving sleep hygiene
Other:
Surveys
Assesses information comprehension, intentions, perceived risk and severity worry, self- efficacy, response efficacy, affect, race, education, age, numeracy, graph literacy, and exercise and sleep behaviors.
Behavioral:
Audio Recording - Exercise
Participants imagine themselves improving exercise
Other:
Text message reminders
-Reminders to practice mental imagery
Text Message Survey
-Assesses exercise behavior, intentions, actions plans, self-efficacy, affect, imagery vividness, and practice.

Locations

Country Name City State
United States Washington University School of Medicine Saint Louis Missouri

Sponsors (3)

Lead Sponsor Collaborator
Washington University School of Medicine National Cancer Institute (NCI), National Institutes of Health (NIH)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change From Baseline to 90-day Follow-up in Self Reported Weekly Minutes of Exercise Baseline and up to 90 days
Primary Difference in Gist Comprehension of Risk Information by Risk Display Format Risk display format = risk ladder, table, or text
Gist comprehension of risk information: being able to extract the bottom-line meaning of information provided by the website (e.g., if exercising decreased heath risk)
Measured by the sum of (4) questions coded as correctly comprehending risk information (1 point) or incorrectly comprehending risk information (0 points), with a total score range of 0=low comprehension to 4=high comprehension. Higher comprehension is considered a better outcome.
All comprehension questions have an additional "don't know" option, which is counted as incorrect.
To limit participant burden, the investigators assessed comprehension for diabetes only, instead of all diseases as planned.
Comprehension will not be assessed for people who report a history of diabetes because they are not given risk information.
Baseline
Primary Difference in Verbatim Comprehension of Risk Information by Risk Communication Strategy Risk communication strategy = risk ladder, table, or text
Verbatim comprehension of risk information: being able to recall the exact information specific to diabetes risk and hours of recommended weekly physical activity
Measured by the sum of (3) questions coded as correctly comprehending information (1 point) or incorrectly comprehending information (0 points), with a total score range of 0=low comprehension to 3=high comprehension. Higher comprehension is considered a better outcome.
All comprehension questions have an additional "don't know" option, which is counted as incorrect.
To limit participant burden, the investigators assessed comprehension for diabetes only, instead of all diseases as planned.
Comprehension will not be assessed for people who report a history of diabetes because they are not given risk information.
Baseline
Primary Difference in Self-reported Intentions to Engage in Physical Activity by Risk Display Format Risk display format = risk ladder, table, or text
Self-reported physical activity intentions is defined as intentions to engage in physical activity in the next 3 months
Measured as an average of three variables, each measured on a 5 point Likert Scale (range: 1=lower intentions to 5=higher intentions)
Higher intentions are considered a better outcome
Baseline
Secondary Effect of the Intervention on Physical Activity Levels as Measured by Maintenance Self-efficacy Maintenance Self-efficacy is defined as being sure one can engage in physical activity even when it is hard
Measured on a 4 point Likert Scale (range: 1=lower Maintenance Self-efficacy to 4=higher Maintenance Self-efficacy)
Higher maintenance self-efficacy is considered a better outcome
Note: to limit participant burden, the investigators used a single item instead of averaging across multiple items
90 days
Secondary Effect of the Intervention on Physical Activity Levels as Measured by Recovery Self-efficacy Recovery Self-efficacy is defined as being sure one can re-engage in physical activity after putting it off
Measured on a 4 point Likert Scale (range: 1=lower recovery Self-efficacy to 4=higher recovery Self-efficacy)
Higher recovery self-efficacy is considered a better outcome
Note: to limit participant burden, the investigators used a single item instead of averaging across multiple items
90 days
Secondary Effect of the Intervention on Physical Activity Levels as Measured by Affective Attitudes to Exercise - Enjoying Behavior Affective Attitudes to Exercise - Enjoying Behavior is defined as thinking getting regular exercise is enjoyable
Measured on a 4 point Likert Scale (range: 1=lower Affective Attitudes to Exercise to 4=higher Affective Attitudes to Exercise)
Higher Affective Attitudes to Exercise - Enjoying Behavior is considered a better outcome
Note: to limit participant burden, the investigators used a single item instead of averaging across multiple items
90 days
Secondary Effect of the Intervention on Physical Activity Levels as Measured by Affective Attitudes to Exercise - Thinking Behavior is Unpleasant Affective Attitudes to Exercise - Thinking Behavior is Unpleasant is defined as not thinking getting regular exercise is unpleasant
Measured on a 4 point Likert Scale (range: 1=lower Affective Attitudes to Exercise to 4=higher Affective Attitudes to Exercise)
Higher Affective Attitudes to Exercise - Thinking Behavior is Unpleasant is considered a better outcome
Note: to limit participant burden, the investigators used a single item instead of averaging across multiple items
90 days
Secondary Effect of the Intervention on Physical Activity Levels as Measured by Perceived Vividness of Self-regulatory Imagery Perceived Vividness of Self-regulatory Imagery is defined as having clear and vivid images of steps towards getting physical activity
Measured as an average of two variables measured on a 4 point Likert Scale (range: 1=lower Perceived Vividness of Self-regulatory Imagery to 4=higher Perceived Vividness of Self-regulatory Imagery)
Higher Perceived Vividness of Self-regulatory Imagery is considered a better outcome
Note: to limit participant burden, the investigators used a single item instead of averaging across multiple items
90 days
Secondary Effect of the Intervention on Physical Activity Levels as Measured by Action Planning Action planning is defined as having a detailed plan about getting adequate physical activity
Measured as an average of three variables measured on a 4 point Likert Scale (range: 1=lower action planning to 4=higher action planning)
Higher action planning is considered a better outcome
Note: to limit participant burden, the investigators used a single item instead of averaging across multiple items
90 days
Secondary Effect of the Intervention on Physical Activity Levels as Measured by Coping Planning Coping planning is defined as having a detailed plan of solving problems that may prevent getting adequate physical activity
Measured on a 4 point Likert Scale (range: 1=lower Coping Planning to 4=higher Coping Planning)
Higher coping planning is considered a better outcome
Note: to limit participant burden, the investigators used a single item instead of averaging across multiple items
90 days
Secondary Effect of the Intervention on Physical Activity Levels as Measured by Action Self-efficacy Action self-efficacy is defined as having the confidence to engage in physical activity
Measured on a 4 point Likert Scale (range: 1=lower Action Self-efficacy to 4=higher Action Self-efficacy)
Higher Action Self-efficacy is considered a better outcome
Note: to limit participant burden, the investigators used a single item instead of averaging across multiple items
90 days
See also
  Status Clinical Trial Phase
Completed NCT05029518 - 3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability Phase 1
Completed NCT05001152 - Taste Assessment of Ozanimod Phase 1
Completed NCT04493255 - A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants Phase 1
Completed NCT03457649 - IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers Phase 1
Completed NCT00995891 - Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
Completed NCT05050318 - Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively Phase 4
Completed NCT05043766 - Evaluation of Oral PF614 Relative to OxyContin Phase 1
Completed NCT04466748 - A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects Phase 1
Completed NCT00746733 - Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC Phase 1
Recruiting NCT05929651 - Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy Phase 4
Completed NCT05954039 - Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect N/A
Completed NCT05045716 - A Study of Subcutaneous Lecanemab in Healthy Participants Phase 1
Active, not recruiting NCT02747927 - Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children Phase 3
Completed NCT05533801 - A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants Phase 1
Not yet recruiting NCT03931369 - Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST) Phase 2
Completed NCT03279146 - A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects Phase 1
Completed NCT06027437 - A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants Phase 1
Recruiting NCT05619874 - Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity N/A
Completed NCT05553418 - Investigational On-body Injector Clinical Study N/A
Completed NCT04092712 - Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers Phase 1